|Narrow your search|
By Research Group
All retinal prostheses target ganglion cells in the retina. However, little is known about the state of ganglion cells in middle to late stages of degeneration when most patients will be candidates for a device. Here, we have undertaken a morphological ...
Introduction For many neuroprosthetic devices, strength-duration curves indicate that the total injected charge determines the response of neurons to electrical stimulation. However, when pulse duration is much longer than the chronaxie of the ...
Introduction: Current technology to restore visual sensitivity in blind patients is entirely non-selective about which retinal ganglion cells (RGCs) are activated. The axons of RGCs make up 15-20 parallel pathways, each of which encodes different ...